expert roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD
In the treatment of plaque psoriasis, small-molecule drugs such as apremilast are not as effective as the injectable therapies that target the inte......READ MORE
expert roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD
There are multiple factors involved in the consideration of systemic treatments for plaque psoriasis. In addition to patient expectations and payor......READ MORE
patient care perspectives by Bruce E. Strober, MD, PhD
Barriers that may undermine optimal care in psoriasis include patient-based, physician-based, and payor-based obstacles. Our featured expert explor......READ MORE
patient care perspectives by Steven R. Feldman, MD, PhD
Many studies have shown links between adopting a healthier lifestyle and an improvement in the severity of plaque psoriasis. Although this area can......READ MORE
clinical topic updates by Steven R. Feldman, MD, PhD
Our featured expert reviews practical strategies for switching psoriasis therapies after treatment failure, including perspectives on patient adher......READ MORE
clinical topic updates by Steven R. Feldman, MD, PhD
As ongoing studies by the National Institutes of Health aim to elucidate the relationship between psoriasis and cardiometabolic diseases, our featu......READ MORE
